
Sign up to save your podcasts
Or


In October last year, the FDA announced a shortage of Adderall due to manufacturing delays.
Now six months later, there is a severe shortage of not just Adderall, but similar drugs that treat ADHD. And it’s wreaking havoc on the lives of the children and adults who have the disorder.
So, what's going on and what can be done to fix the problem? Dr. David Pate, former CEO of St. Luke's Health System and current member of the Idaho Coronavirus Task Force, joined Idaho Matters to talk more about the issue.
By Boise State Public Radio4.5
102102 ratings
In October last year, the FDA announced a shortage of Adderall due to manufacturing delays.
Now six months later, there is a severe shortage of not just Adderall, but similar drugs that treat ADHD. And it’s wreaking havoc on the lives of the children and adults who have the disorder.
So, what's going on and what can be done to fix the problem? Dr. David Pate, former CEO of St. Luke's Health System and current member of the Idaho Coronavirus Task Force, joined Idaho Matters to talk more about the issue.

90,956 Listeners

44,008 Listeners

38,594 Listeners

43,601 Listeners

38,812 Listeners

9,248 Listeners

4,005 Listeners

8,476 Listeners

12,155 Listeners

6,483 Listeners

4,675 Listeners

16,473 Listeners

12 Listeners

435 Listeners

10 Listeners